Eisai, Biogen get U.S. FDA approval for Alzheimer’s drug, apply for full approval
Jan 7 (Reuters) - The U.S. Food and Drug Administration on Friday approved the Alzheimer's drug ...
Read moreJan 7 (Reuters) - The U.S. Food and Drug Administration on Friday approved the Alzheimer's drug ...
Read moreAssets managed by sovereign wealth funds fell nearly 8%Assets of public pension funds dropped almost 6%LONDON, ...
Read moreDec 7 (Reuters) - The first ever auction of offshore wind development rights off the coast ...
Read moreTesla ships first Semi to PepsiCo five years after unveiling itNo details on orders or capacity ...
Read morePMI needs 90% stake for compulsory buyout of minoritiesPMI believes that target can eventually be reachedPMI ...
Read moreLONDON, Oct 25 (Reuters) - European stocks rose in early trading on Tuesday, as investors took ...
Read moreOSLO, Oct 25 (Reuters) - Norwegian aluminium producer Norsk Hydro (NHY.OL) on Tuesday posted third-quarter profits ...
Read moreA look at the day ahead in European and global markets from Ankur BanerjeeWith investors' mood ...
Read moreLONDON, Oct 12 (Reuters) - European stocks held steady in early trading on Wednesday, while sterling ...
Read moreOct 7 (Reuters) - The Biden administration on Friday published a sweeping set of export controls, ...
Read more© 2022 TheDailyStock.News